2.2 Healthcare
To destabilize the Cuban healthcare system has been a
systematic purpose of the US hostility and blockade policy for over four decades.
A fundamental priority within the political set of
actions taken against the healthcare sector seeks to destabilize the scientific and human
resources basis of the medical sector, by an ongoing encouragement to defection. Thus,
since the early 60s, no US Administration has given up its attempt to urge the brain
drain from this sector. As a result of these campaigns, 50% of the physicians from those
early years left the country.
Likewise, as part of that policy, all possibilities
of technologic and scientific transfer were eliminated, as well as the possibilities for
medical staff upgrading by hindering access to medical literature, exchanges of
experiences, the attendance to medical events and congresses.
American pharmaceutical enterprises and medical
equipment manufacturers and their subsidiaries in third countries produce over 50 percent
of the new pharmaceutical drugs and over 80 percent of biotech products, with patents with
a 17-year validity. On the other hand, and with especial impetus since last decade, US
enterprises have been extensively involved in the accelerated process of strategic
acquisitions, mergers, and alliances among enterprises of this sector. Thus, enterprises
that used to supply Cuba with medical equipment and products stopped those supplies as a
consequence of the promulgation of the Torricelli Act4.
All specialties of the healthcare system have
suffered serious problems regarding availability of medicines, expendable material,
instruments, equipment and parts, while in some specialties some equipment have become
obsolete, thus worsening the situation. (See attachment 1).
In some specialties, the consequences of this deficit
have been disastrous, not only to the ailment of patients and their relatives, but also to
the medical and nursing staff that, on certain occasions has felt powerless when trying to
save a life or heal a disease, for not having timely at their disposal the required US
medicine or equipment.
Eight-month-boy Johnatan Guerra Blancos parents
are two of the many people who can give evidence of their suffering. If they had had the
opportunity of acquiring a device known as "Stent", which was denied by Johnson
& Johnson enterprise, this Cuban babys suffering would have been less.
Among the most negative impacts of this policy are
those related to diagnoses tests such as: x-rays, clinical and microbiological lab
analysis, biopsy and endoscopies.
There are many cases that speak for themselves. Among
them, that of Murex International Technologies enterprise that, to avoid retaliatory
actions from the US government, prohibited the supply of diagnosis equipment to Cuba from
the United Kingdom-- up to that moment this equipment had been provided by one of its
companies in that country. This brought about a sudden interruption of an important source
of supplies, the search for a new supplier, a period of waiting of at least three months
before being able to use these products and an increase in costs.
Cuban enterprises devoted to the trade of medical and
healthcare equipment, technology and materials, cannot purchase lab equipment from
well-known companies as Baxter, Healthcare, Drake Willock, Vitalmex Interamericana, S.A.,
as well as other US companies that refuse to sell equipment, expendable material and
accessories to Cuban hospitals for dialysis and tertiary care. Likewise, modern methods
used for continuous cycle peritoneal dialysis cannot be purchased for Cuban hospitals.
Regarding other specialties, it should be added that
there have been remarkable restrictions in the purchase of high-level basic equipment and
sets of instruments for the development of ophthalmology, ophthalmologic surgery and
microsurgery programs.
Cardiology and cardiovascular surgery have also been
meaningfully damaged by the regulations and laws related to Cuba. Specialists from
countrys main children cardiovascular center have explained how the lives of
patients with serious heart conditions have been in danger due to the inability to buy
more modern and better anti-arrhythmic drugs.
In the last few years, Cuba has not had access to
over 16 cytostatic drugs for cancer therapy, the majority of which are manufactured by US
companies. Besides this, there are difficulties with the use of Radiotherapy due to
deterioration and/or shortage of equipment, thus rendering the cancer therapy more
expensive, complicated and mutilated -- with the minimum necessary quality.
As an example, we should point out the dramatic case
of 9-year-old-boy, Yordanky Rodríguez Ramírez, with a highly risky Acute Lymphoblastic
Leukemia. This boys treatment has constantly been modified since the most suitable
medicines have not been available; this has had an unfavorable effect on the
patients evolution.